Document is current
Any future updates will be listed below
-
Authors
Akcakaya, Pinar
Bobbin, Maggie L.
Guo, Jimmy A.
Malagon-Lopez, Jose
Clement, Kendell
Garcia, Sara P.
Fellows, Mick D.
Porritt, Michelle J.
Firth, Mike A.
Carreras, Alba
Baccega, Tania
Seeliger, Frank
Bjursell, Mikael
Tsai, Shengdar Q.
Nguyen, Nhu T.
Nitsch, Roberto
Mayr, Lorenz M.
Pinello, Luca
Bohlooly-Y, Mohammad
Aryee, Martin J.
Maresca, Marcello
Joung, J. Keith
- License Information
-
More Information
Article History
Received: 27 February 2018
Accepted: 23 July 2018
First Online: 12 September 2018
Competing interests
: J.K.J. has financial interests in Beam Therapeutics, Blink Therapeutics, Editas Medicine, Endcadia, Monitor Biotechnologies (formerly known as Beacon Genomics), Pairwise Plants, Poseida Therapeutics and Transposagen Biopharmaceuticals. M.J.A. and S.Q.T. have financial interests in Monitor Biotechnologies. J.K.J.’s and M.J.A.’s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. S.Q.T. and J.K.J. are co-inventors on a patent describing the CIRCLE-seq method. P.A., M.D.F., M.J.P., M.A.F., F.S., M.B., R.N., M.B.Y. and M.M. are employees and shareholders of AstraZeneca. L.M.M. is an employee and shareholder of GE Healthcare and a shareholder of AstraZeneca.
